H Lundbeck
H. Lundbeck is a global specialty pharmaceutical company dedicated to discovering, developing, and commercializing innovative therapeutics for brain diseases. The firm focuses its research and development efforts primarily on psychiatric and neurological disorders, including major depressive disorder, schizophrenia, Parkinson's disease, and Alzheimer's disease. Its product portfolio features established pharmaceutical brands prescribed by medical professionals to treat complex central nervous system conditions worldwide. Principal revenue drivers stem from global commercial sales of prescription medicines to healthcare providers, hospitals, and distribution partners. The company maintains a significant international scale and a specialized market position within neuroscience pharmaceuticals, serving patients across numerous countries. Lundbeck is officially headquartered in Valby, Denmark, and its shares are publicly listed and traded on the Nasdaq Copenhagen exchange.
42 of the funds FundTelligence covers report a position in H Lundbeck.
- Legal name
- H Lundbeck A/S
- Sector
- Health Care
- Country
- Denmark
- Funds holding it
- 42
- Exposure themes
- Depression & Mood Disorders, Mental Health, Psychiatry
Funds holding H Lundbeck
- HealthInvest Small & Mid Cap Healthcare — HealthInvest · 2.6 % (partially disclosed portfolio, September 2026)
- Schroder ISF Nordic Smaller Companies — Schroders · 2.48 % (full portfolio disclosed, June 2026)
- Schroder ISF European Value — Schroders · 2.18 % (full portfolio disclosed, June 2026)
- SKAGEN Vekst — Storebrand · 2.04 % (full portfolio disclosed, October 2026)
- Handelsbanken Nordiske SMB — Handelsbanken · 1.54 % (full portfolio disclosed, October 2026)
- Nordea Virksomhedsobligationer — Nordea Funds · 1.45 % (full portfolio disclosed, July 2026)
- Nordea European Corporate Bond — Nordea Funds · 1.38 % (full portfolio disclosed, July 2026)
- Nordea European Corporate Sustainable Stars Bond — Nordea Funds · 1.19 % (full portfolio disclosed, July 2026)
Showing the 8 largest of 42 funds holding it.